American Portfolios Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $205K | Sell |
297
-1
| -0.3% | -$689 | 0.01% | 1009 |
|
|
2022
Q2 | $176K | Sell |
298
-223
| -43% | -$132K | 0.01% | 1105 |
|
|
2022
Q1 | $364K | Buy |
521
+203
| +64% | +$142K | 0.01% | 880 |
|
|
2021
Q4 | $201K | Sell |
318
-335
| -51% | -$212K | 0.01% | 1161 |
|
|
2021
Q3 | $395K | Buy |
653
+237
| +57% | +$143K | 0.01% | 816 |
|
|
2021
Q2 | $232K | Sell |
416
-2,300
| -85% | -$1.28M | 0.01% | 1043 |
|
|
2021
Q1 | $1.29M | Buy |
2,716
+2,234
| +463% | +$1.06M | 0.06% | 326 |
|
|
2020
Q4 | $233K | Sell |
482
-91
| -16% | -$44K | 0.01% | 835 |
|
|
2020
Q3 | $321K | Sell |
573
-884
| -61% | -$495K | 0.02% | 631 |
|
|
2020
Q2 | $909K | Sell |
1,457
-984
| -40% | -$614K | 0.06% | 293 |
|
|
2020
Q1 | $1.19M | Buy |
2,441
+2,300
| +1,631% | +$1.12M | 0.1% | 190 |
|
|
2019
Q4 | $52.9K | Buy |
141
+14
| +11% | +$5.26K | ﹤0.01% | 1318 |
|
|
2019
Q3 | $35.2K | Sell |
127
-7
| -5% | -$1.94K | ﹤0.01% | 1430 |
|
|
2019
Q2 | $41.9K | Sell |
134
-125
| -48% | -$39.1K | ﹤0.01% | 1348 |
|
|
2019
Q1 | $106K | Buy |
259
+151
| +140% | +$62K | 0.01% | 865 |
|
|
2018
Q4 | $40.3K | Sell |
108
-108
| -50% | -$40.3K | 0.01% | 1106 |
|
|
2018
Q3 | $87.3K | Buy |
216
+99
| +85% | +$40K | 0.01% | 885 |
|
|
2018
Q2 | $40.4K | Hold |
117
| – | – | 0.01% | 1160 |
|
|
2018
Q1 | $40.3K | Buy |
117
+27
| +30% | +$9.3K | 0.01% | 1118 |
|
|
2017
Q4 | $33.8K | Buy |
+90
| New | +$33.8K | 0.01% | 1141 |
|